A real-world investigation of drug-induced hyperglycemia and diabetes mellitus in pediatric populations using the FDA adverse event reporting system
Our study systematically delineated the risk signals implicated in pediatric DIH/DIDM. Clinicians should heighten surveillance when prescribing potentially diabetogenic agents and pay particular attention to age-related windows of susceptibility.
Authors
- Lijuan Teng
- Xue Zhao
- Xiutian Sun
- Xiaohua Qu
- Meng Ma
Institutions
- Weifang People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-28
- DOI
- https://doi.org/10.3389/fmed.2026.1751155
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00